Top compounds associated with response to GPR17


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.073 0.01
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA austocystin d CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BX-912 GDSC1000 pan-cancer AAC 0.072 0.02
mRNA linifanib GDSC1000 pan-cancer AAC 0.083 0.02
mRNA SU11274 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA PD318088 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.072 0.02
Download CSV